Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Return on Assets: 2011-2019

Historic Return on Assets for Neurocrine Biosciences (NBIX) over the last 9 years, with Dec 2019 value amounting to 0.03%.

  • Neurocrine Biosciences' Return on Assets fell 4.00% to 0.02% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.02%, marking a year-over-year decrease of 4.00%. This contributed to the annual value of 0.03% for FY2019, which is 1.00% up from last year.
  • Neurocrine Biosciences' Return on Assets amounted to 0.03% in FY2019, which was up 38.08% from 0.02% recorded in FY2018.
  • In the past 5 years, Neurocrine Biosciences' Return on Assets registered a high of 0.03% during FY2019, and its lowest value of -0.34% during FY2016.
  • Its 3-year average for Return on Assets is -0.06%, with a median of 0.02% in 2018.
  • Per our database at Business Quant, Neurocrine Biosciences' Return on Assets declined by 8bps in 2016 and then increased by 26bps in 2018.
  • Yearly analysis of 5 years shows Neurocrine Biosciences' Return on Assets stood at -0.26% in 2015, then decreased by 8bps to -0.34% in 2016, then increased by 9bps to -0.24% in 2017, then climbed by 26bps to 0.02% in 2018, then increased by 1bps to 0.03% in 2019.